首页> 美国卫生研究院文献>Chemical Science >Aromatic secondary amine-functionalized fluorescent NO probes: improved detection sensitivity for NO and potential applications in cancer immunotherapy studies
【2h】

Aromatic secondary amine-functionalized fluorescent NO probes: improved detection sensitivity for NO and potential applications in cancer immunotherapy studies

机译:芳香族仲胺官能化荧光NO探针:提高了NO的检测灵敏度并在癌症免疫疗法研究中具有潜在的应用

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Tumor-associated macrophages (TAMs), constituting up to 50% of the solid tumor mass and commonly having a pro-tumoral M2 phenotype, are closely associated with decreased survival in patients. Based on the highly dynamic properties of macrophages, in recent years the repolarization of TAMs from pro-tumoral M2 phenotype to anti-tumoral M1 phenotype by various strategies has emerged as a promising cancer immunotherapy approach for improving cancer therapy. Herein, we present an aromatic secondary amine-functionalized Bodipy dye >1 and its mitochondria-targetable derivative >Mito1 as fluorescent NO probes for discriminating M1 macrophages from M2 macrophages in terms of their difference in inducible NO synthase (iNOS) levels. The two probes possess the unique ability to simultaneously respond to two secondary oxides of NO, i.e., N2O3 and ONOO, thus being more sensitive and reliable for reflecting intracellular NO than most of the existing fluorescent NO probes that usually respond to N2O3 only. With >1 as a representative, the discrimination between M1 and M2 macrophages, evaluation of the repolarization of TAMs from pro-tumoral M2 phenotype to anti-tumoral M1 phenotype, and visualization of NO communication during the immune-mediated phagocytosis of cancer cells by M1 macrophages have been realized. These results indicate that our probes should hold great potential for imaging applications in cancer immunotherapy studies and relevant anti-cancer drug screening.
机译:肿瘤相关巨噬细胞(TAM)占实体瘤块的50%,通常具有肿瘤前M2表型,与患者生存率下降密切相关。基于巨噬细胞的高度动态特性,近年来,通过各种策略将TAM从极化前M2表型重新极化为抗肿瘤M1表型已成为一种有前途的癌症免疫疗法,用于改善癌症治疗。在这里,我们介绍芳香族仲胺官能化的Bodipy染料> 1 及其线粒体可靶向衍生物> Mito1 作为荧光NO探针,用于区分M2巨噬细胞和M2巨噬细胞诱导型NO合酶(iNOS)的水平。这两种探针具有独特的能力,能够同时响应NO的两种二次氧化物,即N2O3和ONOO ,因此比大多数现有的荧光NO探针更灵敏,更可靠地反映细胞内的NO。通常仅对N2O3做出反应。以> 1 为代表,区分M1和M2巨噬细胞,评估TAMs从肿瘤前M2表型向抗肿瘤M1表型的重新极化,并在免疫介导期间可视化NO通讯已经实现了通过M1巨噬细胞对癌细胞的吞噬作用。这些结果表明,我们的探针在癌症免疫疗法研究和相关的抗癌药物筛选中应具有巨大的成像应用潜力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号